The research group of Prof. Sanjiv Luther at the Department of Immunobiology of the University of Lausanne has discovered ...

Lung immune diseases have become a major global public health burden, with incidence increasing over the past two decades—especially in industrialized ...

FibroBiologics, Inc., a biotechnology company focused on developing therapies for chronic diseases using fibroblasts, announced that Dr. Chuo Fang presented research at the Society for Investigative ...